Literature DB >> 35931052

Loss of function of OTUD7A in the schizophrenia- associated 15q13.3 deletion impairs synapse development and function in human neurons.

Alena Kozlova1, Siwei Zhang2, Alex V Kotlar3, Brendan Jamison1, Hanwen Zhang1, Serena Shi4, Marc P Forrest5, John McDaid6, David J Cutler7, Michael P Epstein7, Michael E Zwick8, Zhiping P Pang9, Alan R Sanders2, Stephen T Warren7, Pablo V Gejman2, Jennifer G Mulle10, Jubao Duan11.   

Abstract

Identifying causative gene(s) within disease-associated large genomic regions of copy-number variants (CNVs) is challenging. Here, by targeted sequencing of genes within schizophrenia (SZ)-associated CNVs in 1,779 SZ cases and 1,418 controls, we identified three rare putative loss-of-function (LoF) mutations in OTU deubiquitinase 7A (OTUD7A) within the 15q13.3 deletion in cases but none in controls. To tie OTUD7A LoF with any SZ-relevant cellular phenotypes, we modeled the OTUD7A LoF mutation, rs757148409, in human induced pluripotent stem cell (hiPSC)-derived induced excitatory neurons (iNs) by CRISPR-Cas9 engineering. The mutant iNs showed a ∼50% decrease in OTUD7A expression without undergoing nonsense-mediated mRNA decay. The mutant iNs also exhibited marked reduction of dendritic complexity, density of synaptic proteins GluA1 and PSD-95, and neuronal network activity. Congruent with the neuronal phenotypes in mutant iNs, our transcriptomic analysis showed that the set of OTUD7A LoF-downregulated genes was enriched for those relating to synapse development and function and was associated with SZ and other neuropsychiatric disorders. These results suggest that OTUD7A LoF impairs synapse development and neuronal function in human neurons, providing mechanistic insight into the possible role of OTUD7A in driving neuropsychiatric phenotypes associated with the 15q13.3 deletion.
Copyright © 2022 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  15q13.3 deletion; OTUD7A; copy number; human iPSC; neurodevelopment; neuron; schizophrenia; synapse; transcriptome; variant

Mesh:

Year:  2022        PMID: 35931052      PMCID: PMC9388388          DOI: 10.1016/j.ajhg.2022.07.001

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.043


  92 in total

1.  The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1.

Authors:  Grigory Krapivinsky; Luba Krapivinsky; Yunona Manasian; Anton Ivanov; Roman Tyzio; Christophe Pellegrino; Yehezkel Ben-Ari; David E Clapham; Igor Medina
Journal:  Neuron       Date:  2003-11-13       Impact factor: 17.173

2.  Neuron-enriched phosphatase and actin regulator 3 (Phactr3)/ nuclear scaffold-associated PP1-inhibiting protein (Scapinin) regulates dendritic morphology via its protein phosphatase 1-binding domain.

Authors:  Tomoaki Miyata; Keietsu Kikuchi; Daisuke Ihara; Maki Kaito; Yuta Ishibashi; Tomoyuki Hakamata; Tetsuya Yamada; Mitsuru Ishikawa; Miho Mizukoshi; Shizuku Shoji; Mamoru Fukuchi; Masaaki Tsuda; Yamato Hida; Toshihisa Ohtsuka; Marisa Kaneda; Akiko Tabuchi
Journal:  Biochem Biophys Res Commun       Date:  2020-05-15       Impact factor: 3.575

Review 3.  The human clinical phenotypes of altered CHRNA7 copy number.

Authors:  Madelyn A Gillentine; Christian P Schaaf
Journal:  Biochem Pharmacol       Date:  2015-06-18       Impact factor: 5.858

4.  The Internet-based MGS2 control sample: self report of mental illness.

Authors:  Alan R Sanders; Douglas F Levinson; Jubao Duan; J Michael Dennis; Rick Li; Kenneth S Kendler; John P Rice; Jianxin Shi; Bryan J Mowry; Farooq Amin; Jeremy M Silverman; Nancy G Buccola; William F Byerley; Donald W Black; Robert Freedman; C Robert Cloninger; Pablo V Gejman
Journal:  Am J Psychiatry       Date:  2010-06-01       Impact factor: 18.112

5.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update.

Authors:  Maxim V Kuleshov; Matthew R Jones; Andrew D Rouillard; Nicolas F Fernandez; Qiaonan Duan; Zichen Wang; Simon Koplev; Sherry L Jenkins; Kathleen M Jagodnik; Alexander Lachmann; Michael G McDermott; Caroline D Monteiro; Gregory W Gundersen; Avi Ma'ayan
Journal:  Nucleic Acids Res       Date:  2016-05-03       Impact factor: 16.971

6.  A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation.

Authors:  Zizhen Yao; Cindy T J van Velthoven; Thuc Nghi Nguyen; Jeff Goldy; Adriana E Sedeno-Cortes; Fahimeh Baftizadeh; Darren Bertagnolli; Tamara Casper; Megan Chiang; Kirsten Crichton; Song-Lin Ding; Olivia Fong; Emma Garren; Alexandra Glandon; Nathan W Gouwens; James Gray; Lucas T Graybuck; Michael J Hawrylycz; Daniel Hirschstein; Matthew Kroll; Kanan Lathia; Changkyu Lee; Boaz Levi; Delissa McMillen; Stephanie Mok; Thanh Pham; Qingzhong Ren; Christine Rimorin; Nadiya Shapovalova; Josef Sulc; Susan M Sunkin; Michael Tieu; Amy Torkelson; Herman Tung; Katelyn Ward; Nick Dee; Kimberly A Smith; Bosiljka Tasic; Hongkui Zeng
Journal:  Cell       Date:  2021-05-17       Impact factor: 66.850

7.  A human forebrain organoid model of fragile X syndrome exhibits altered neurogenesis and highlights new treatment strategies.

Authors:  Yunhee Kang; Ying Zhou; Yujing Li; Yanfei Han; Jie Xu; Weibo Niu; Ziyi Li; Shiying Liu; Hao Feng; Wen Huang; Ranhui Duan; Tianmin Xu; Nisha Raj; Feiran Zhang; Juan Dou; Chongchong Xu; Hao Wu; Gary J Bassell; Stephen T Warren; Emily G Allen; Peng Jin; Zhexing Wen
Journal:  Nat Neurosci       Date:  2021-08-19       Impact factor: 24.884

8.  Common variants conferring risk of schizophrenia.

Authors:  Hreinn Stefansson; Roel A Ophoff; Stacy Steinberg; Ole A Andreassen; Sven Cichon; Dan Rujescu; Thomas Werge; Olli P H Pietiläinen; Ole Mors; Preben B Mortensen; Engilbert Sigurdsson; Omar Gustafsson; Mette Nyegaard; Annamari Tuulio-Henriksson; Andres Ingason; Thomas Hansen; Jaana Suvisaari; Jouko Lonnqvist; Tiina Paunio; Anders D Børglum; Annette Hartmann; Anders Fink-Jensen; Merete Nordentoft; David Hougaard; Bent Norgaard-Pedersen; Yvonne Böttcher; Jes Olesen; René Breuer; Hans-Jürgen Möller; Ina Giegling; Henrik B Rasmussen; Sally Timm; Manuel Mattheisen; István Bitter; János M Réthelyi; Brynja B Magnusdottir; Thordur Sigmundsson; Pall Olason; Gisli Masson; Jeffrey R Gulcher; Magnus Haraldsson; Ragnheidur Fossdal; Thorgeir E Thorgeirsson; Unnur Thorsteinsdottir; Mirella Ruggeri; Sarah Tosato; Barbara Franke; Eric Strengman; Lambertus A Kiemeney; Ingrid Melle; Srdjan Djurovic; Lilia Abramova; Vasily Kaleda; Julio Sanjuan; Rosa de Frutos; Elvira Bramon; Evangelos Vassos; Gillian Fraser; Ulrich Ettinger; Marco Picchioni; Nicholas Walker; Timi Toulopoulou; Anna C Need; Dongliang Ge; Joeng Lim Yoon; Kevin V Shianna; Nelson B Freimer; Rita M Cantor; Robin Murray; Augustine Kong; Vera Golimbet; Angel Carracedo; Celso Arango; Javier Costas; Erik G Jönsson; Lars Terenius; Ingrid Agartz; Hannes Petursson; Markus M Nöthen; Marcella Rietschel; Paul M Matthews; Pierandrea Muglia; Leena Peltonen; David St Clair; David B Goldstein; Kari Stefansson; David A Collier
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

9.  Copy number variation in schizophrenia in Sweden.

Authors:  J P Szatkiewicz; C O'Dushlaine; G Chen; K Chambert; J L Moran; B M Neale; M Fromer; D Ruderfer; S Akterin; S E Bergen; A Kähler; P K E Magnusson; Y Kim; J J Crowley; E Rees; G Kirov; M C O'Donovan; M J Owen; J Walters; E Scolnick; P Sklar; S Purcell; C M Hultman; S A McCarroll; P F Sullivan
Journal:  Mol Psychiatry       Date:  2014-04-29       Impact factor: 15.992

10.  Neuronal impact of patient-specific aberrant NRXN1α splicing.

Authors:  Erin Flaherty; Shijia Zhu; Natalie Barretto; Esther Cheng; P J Michael Deans; Michael B Fernando; Nadine Schrode; Nancy Francoeur; Alesia Antoine; Khaled Alganem; Madeline Halpern; Gintaras Deikus; Hardik Shah; Megan Fitzgerald; Ian Ladran; Peter Gochman; Judith Rapoport; Nadejda M Tsankova; Robert McCullumsmith; Gabriel E Hoffman; Robert Sebra; Gang Fang; Kristen J Brennand
Journal:  Nat Genet       Date:  2019-11-29       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.